SCHEMBL5236919

SCHEMBL5236919

CC(C)CCOC(=O)C1(C=CC(=O)O)CC(OCc2ccccc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.40
HCAR2 Q8TDS4 2/20 0.39
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
BCHE P06276 2/20 0.37
ALDH1A1 P00352 3/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
EPHX2 P34913 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5236909 1.00 PPARG (0.40) PPARGHCAR2CHRNB2CHRNB4CHRNA3
SCHEMBL5236350 0.82 PPARG (0.43) PPARGBCHEALDH1A1HTTLMNA
SCHEMBL5231539 0.75 PPARG (0.37) PPARGBCHEALDH1A1LMNATDP1
SCHEMBL5233528 0.74 PPARG (0.36) PPARGBCHEALDH1A1LMNATDP1
SCHEMBL5235374 0.74 KLK7 (0.40) PPARGEPHX2L3MBTL1CTSL
SCHEMBL5235544 0.74 BRD4 (0.37) PPARGBCHE
SCHEMBL5234267 0.70 ITGA4 (0.33) PPARGBCHELMNAEPHX2L3MBTL1
SCHEMBL16344671 0.69 ALDH1A1 (0.67) ALDH1A1HTTNPSR1LMNATDP1
SCHEMBL4310339 0.69 TSHR (0.45) BCHEALDH1A1LMNAEPHX2CYP3A4
SCHEMBL23285147 0.69 ALDH1A1 (0.45) BCHEALDH1A1LMNATDP1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0990654-B1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2007-11-14 EP disclosed
US-6448266-B1 COMPOUNDS SUCH AS 2-AMINO-7-(3-(3-AMINO-1-FLUOROCYCLOBUTAN-3-YL)PYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUORO-1-CYCLOPROPYL)-8-METHYL-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS, PNEUMOCOCCUS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-09-10 US disclosed
EP-0990654-A1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed